Cover Image
Market Research Report

Sleep Apnea Diagnostics Market by Product (Polysomnography (PSG) Device, Actigraphy System, Respiratory Polygraph, Sleep Apnea Screening Device, and Oximeter) and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025

Published by Allied Market Research Product code 763998
Published Content info 180 Pages
Delivery time: 2-3 business days
Price
Back to Top
Sleep Apnea Diagnostics Market by Product (Polysomnography (PSG) Device, Actigraphy System, Respiratory Polygraph, Sleep Apnea Screening Device, and Oximeter) and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025
Published: December 18, 2018 Content info: 180 Pages
Description

Title:
Sleep Apnea Diagnostics Market by Product (Polysomnography (PSG) Device, Actigraphy System, Respiratory Polygraph, Sleep Apnea Screening Device, and Oximeter) and End User (Hospitals & Sleep Laboratories and Home Care Settings): Global Opportunity Analysis and Industry Forecast, 2018 - 2025 .

Sleep Apnea Diagnostics Market Overview:

The global sleep apnea diagnostics market was valued at $99million in 2017, and is expected to reach $168 million by 2025, registering a CAGR of 6.8% from 2018 to 2025.

Sleep apnea is a sleep disorder that fluctuates with the patient's breathing pattern. It may decrease or even stop patient's breathing completely during sleep. In few cases, it may pause the breathing (called apnea), which can last 10 seconds or longer and can occur 30 times or more in an hour. Symptoms of sleep apnea include daytime sleepiness, loud snoring, and restless sleep. Approximately 18 million Americans suffer from sleep apnea, while only 20% have been diagnosed and treated.

The major key factors that drive the growth of the sleep apnea diagnostics market include rise in sedentary lifestyle diseases such as diabetes & others and surge in geriatric population. Obesity is considered one of the major risk factor for the development and progression of sleep apnea. In addition, technological advancements to make products more comfortable for patients and considerable upsurge in sleep apnea disorders boost the growth of the global market. However, high cost associated with these devices, limited reimbursement of these devices, and low patient awareness regarding sleep apnea are projected to hinder the market growth. Moreover, increase in preference for home healthcare devices among patients is projected to create lucrative growth opportunities in the near future.

The global sleep apnea diagnostics market is segmented based on product and region. Based on product, the market is divided into polysomnography (PSG) device, actigraphy system, respiratory polygraph, sleep apnea screening device, and oximeter. Based on end user, the market is bifurcated into hospitals & sleep laboratories and home care settings. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits for Sleep Apnea Diagnostics Market:

The study provides an in-depth analysis of the global sleep apnea diagnostics market along with the current trends and future estimations to elucidate the imminent investment pockets.

A comprehensive analysis of the factors that drive and restrict the market growth is provided.

A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.

An extensive analysis of the key segments of the industry helps understand the global trends in the sleep apnea diagnostics market.

Key players and their strategies are provided to understand the competitive outlook of the industry.

Sleep Apnea Diagnostics Key Market Segments:

By Product

  • Polysomnography Device (PSG)
  • Clinical PSG Device
  • Ambulatory PSG Device
  • Sleep Apnea Screening Device
  • Actigraphy Monitoring Device
  • Respiratory Polygraph
  • Oximeter
  • Finger Tip Oximeter
  • Handheld Oximeter
  • Wrist-worn Oximeter
  • Tabletop Oximeter
  • Others

By End User

  • Hospitals & Sleep Laboratories
  • Home Care Settings

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Saudi Arabia
  • South Africa
  • Brazil
  • Rest of LAMEA

KEY MARKET PLAYERS:

  • Cadwell Laboratories Inc.
  • DeVilbiss Healthcare LLC.
  • Koninklijke Philips N.V
  • Medtronic plc
  • Mindray
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • Resmed
  • Smiths Medical
  • SomnoMedics

The other players in the value chain include (profiles not included in the report):

  • Cleveland Medical Devices, Inc.
  • Compumedics Ltd.
  • Fisher & Paykel Healthcare Limited
  • Vyaire Medical, Inc
  • Becton, Dickinson and Company
  • BMC Medical Co., Ltd
Table of Contents
Product Code: LI_184666

Table of Contents

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key benefits for stakeholders
  • 1.3. Key market segments
  • 1.4. Research methodology
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top investment pockets
  • 3.3. Top player positioning, 2017
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in prevalence of obesity across the globe
      • 3.4.1.2. Increase in number of employees working in shifts and under stressful work conditions
      • 3.4.1.3. Technological advancements in sleep apnea diagnostic devices
    • 3.4.2. Restraints
      • 3.4.2.1. High cost associated with the sleep apnea diagnostic devices
      • 3.4.2.2. Lack of awareness among patients regarding sleep apnea
    • 3.4.3. Opportunity
      • 3.4.3.1. Untapped markets in developing economies

CHAPTER 4: SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Polysomnography device (PSG)
    • 4.2.1. Key trends and opportunities
    • 4.2.2. List of Distributors
    • 4.2.3. Market size and forecast
    • 4.2.4. Market analysis, by country
      • 4.2.4.1. Clinical PSG Device
      • 4.2.4.2. Market size and forecast
      • 4.2.4.3. Ambulators PSG Device
      • 4.2.4.4. Market size and forecast
  • 4.3. Sleep apnea screening device
    • 4.3.1. Key trends and opportunities
    • 4.3.2. List of ditributors
    • 4.3.3. Market size and forecast
    • 4.3.4. Market analysis, by country
  • 4.4. Actigraphy monitoring device
    • 4.4.1. Key trends and opportunities
    • 4.4.2. List of distributors
    • 4.4.3. Market size and forecast
    • 4.4.4. Market analysis, by country
  • 4.5. Respiratory polygraph
    • 4.5.1. Key trends and opportunities
    • 4.5.2. List of distributors
    • 4.5.3. Market size and forecast
    • 4.5.4. Market analysis, by country
  • 4.6. Oximeter
    • 4.6.1. Key trends and opportunities
    • 4.6.2. List of distributors
    • 4.6.3. Market size and forecast
    • 4.6.4. Market analysis, by country
    • 4.6.5. Finger Tip Oximeter
      • 4.6.5.1. Market size and forecast
    • 4.6.6. Handheld Oximeter
      • 4.6.6.1. Market size and forecast
    • 4.6.7. Wrist-worn Oximeter
      • 4.6.7.1. Market size and forecast
    • 4.6.8. Tabletop Oximeter
      • 4.6.8.1. Market size and forecast

CHAPTER 5: SLEEP APNEA DIAGNOSTICS MARKET, BY END USER

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Hospitals & sleep laboratories
    • 5.2.1. List of distributors
    • 5.2.2. Market size and forecast
    • 5.2.3. Market analysis, by country
  • 5.3. Home care settings
    • 5.3.1. List of distributors
    • 5.3.2. Market size and forecast
    • 5.3.3. Market analysis, by country

CHAPTER 6: SLEEP APNEA DIAGNOSTICS MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. North America
    • 6.2.1. Key trends and opportunities
    • 6.2.2. List of distributors
    • 6.2.3. North America market size and forecast, by country
      • 6.2.3.1. U.S. market size and forecast, by product
      • 6.2.3.2. U.S. market size and forecast, by end user
      • 6.2.3.3. Canada market size and forecast, by product
      • 6.2.3.4. Canada market size and forecast, by end user
      • 6.2.3.5. Mexico market size and forecast, by product
      • 6.2.3.6. Mexico market size and forecast, by end user
    • 6.2.4. North America market size and forecast, by product
    • 6.2.5. North America market size and forecast, by end user
  • 6.3. Europe
    • 6.3.1. Key trends and opportunities
    • 6.3.2. List of distributors
    • 6.3.3. Europe market size and forecast, by country
      • 6.3.3.1. Germany market size and forecast, by product
      • 6.3.3.2. Germany market size and forecast, by end user
      • 6.3.3.3. UK market size and forecast, by product
      • 6.3.3.4. UK market size and forecast, by end user
      • 6.3.3.5. France market size and forecast, by product
      • 6.3.3.6. France market size and forecast, by end user
      • 6.3.3.7. Italy market size and forecast, by product
      • 6.3.3.8. Italy market size and forecast, by end user
      • 6.3.3.9. Spain market size and forecast, by product
      • 6.3.3.10. Spain market size and forecast, by end user
      • 6.3.3.11. Rest of Europe market size and forecast, by Product
      • 6.3.3.12. Rest of Europe market size and forecast, by end user
    • 6.3.4. Europe market size and forecast, by product
    • 6.3.5. Europe market size and forecast, by end user
  • 6.4. Asia-Pacific
    • 6.4.1. Key trends and opportunities
    • 6.4.2. List of distributors
    • 6.4.3. Asia-Pacific market size and forecast, by country
      • 6.4.3.1. Japan market size and forecast, by product
      • 6.4.3.2. Japan market size and forecast, by end user
      • 6.4.3.3. China market size and forecast, by product
      • 6.4.3.4. China market size and forecast, by end user
      • 6.4.3.5. India market size and forecast, by product
      • 6.4.3.6. India market size and forecast, by end user
      • 6.4.3.7. Australia market size and forecast, by product
      • 6.4.3.8. Australia market size and forecast, by end user
      • 6.4.3.9. Rest of Asia-Pacific market size and forecast, by product
      • 6.4.3.10. Rest of Asia-Pacific market size and forecast, by end user
    • 6.4.4. Asia-Pacific market size and forecast, by product
    • 6.4.5. Asia-Pacific market size and forecast, by end user
  • 6.5. LAMEA
    • 6.5.1. Key market trends and opportunities
    • 6.5.2. List of distributors
    • 6.5.3. LAMEA market size and forecast, by country
      • 6.5.3.1. Brazil market size and forecast, by product
      • 6.5.3.2. Brazil market size and forecast, by end user
      • 6.5.3.3. South Africa market size and forecast, by product
      • 6.5.3.4. South Africa market size and forecast, by end user
      • 6.5.3.5. Saudi Arabia market size and forecast, by product
      • 6.5.3.6. Saudi Arabia market size and forecast, by end user
      • 6.5.3.7. Rest of LAMEA market size and forecast, by product
      • 6.5.3.8. Rest of LAMEA market size and forecast, by end user
    • 6.5.4. LAMEA market size and forecast, by product
    • 6.5.5. LAMEA market size and forecast, by end user

CHAPTER 7: COMPANY PROFILES

  • 7.1. CADWELL INDUSTRIES INC.
    • 7.1.1. Company overview
    • 7.1.2. Company snapshot
    • 7.1.3. Operating business segments
    • 7.1.4. Product portfolio
  • 7.2. DEVILBISS HEALTHCARE
    • 7.2.1. Company overview
    • 7.2.2. Company snapshot
    • 7.2.3. Operating business segments
    • 7.2.4. Product portfolio
  • 7.3. KONINKLIJKE PHILIPS N.V. (PHILIPS)
    • 7.3.1. Company overview
    • 7.3.2. Company snapshot
    • 7.3.3. Operating business segments
    • 7.3.4. Product portfolio
    • 7.3.5. Business performance
    • 7.3.6. Key Strategic Moves:
  • 7.4. MEDTRONIC PLC.
    • 7.4.1. Company overview
    • 7.4.2. Company snapshot
    • 7.4.3. Operating business segment
    • 7.4.4. Product portfolio
    • 7.4.5. Business performance
  • 7.5. MINDRAY MEDICAL INTERNATIONAL LIMITED
    • 7.5.1. Company overview
    • 7.5.2. Operating business segment
  • 7.6. NATUS MEDICAL INCORPORATED
    • 7.6.1. Company overview
    • 7.6.2. Company snapshot
    • 7.6.3. Product portfolio
    • 7.6.4. Operating business segments
    • 7.6.5. Business performance
  • 7.7. NIHON KOHDEN CORPORATION
    • 7.7.1. Company overview
    • 7.7.2. Company snapshot
    • 7.7.3. Operating business segments
    • 7.7.4. Product portfolio
    • 7.7.5. Business performance
  • 7.8. RESMED INC.
    • 7.8.1. Company overview
    • 7.8.2. Company snapshot
    • 7.8.3. Operating business segment
    • 7.8.4. Product portfolio
    • 7.8.5. Business performance
  • 7.9. SMITHS GROUP PLC. (SMITHS MEDICAL)
    • 7.9.1. Company overview
    • 7.9.2. Company snapshot
    • 7.9.3. Operating business segments
    • 7.9.4. Product portfolio
    • 7.9.5. Business performance
    • 7.9.6. Key Strategic Moves:
  • 7.10. SOMNOMEDICS GmbH
    • 7.10.1. Company overview
    • 7.10.2. Company snapshot
    • 7.10.3. Operating business segments
    • 7.10.4. Product portfolio

List of Tables

LIST OF TABLES

  • TABLE 01. GLOBAL SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 02. SLEEP APNEA DIAGNOSTICS MARKET, FOR POLYSOMNOGRAPHY DEVICE (PSG) BY REGION, 20172025 ($MILLION)
  • TABLE 03. GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR SLEEP APNEA SCREENING DEVICE, BY REGION, 20172025 ($MILLION)
  • TABLE 04. SLEEP APNEA DIAGNOSTICS MARKET FOR ACTIGRAPHY MONITORING DEVICE, BY REGION, 20172025 ($MILLION)
  • TABLE 05. GLOBAL OTHER SLEEP APNEA DIAGNOSTICS MARKET FOR RESPIRATORY POLYGRAPHS, BY REGION, 20172025 ($MILLION)
  • TABLE 06. GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR OXIMETER, BY REGION, 20172025 ($MILLION)
  • TABLE 07. GLOBAL SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 08. GLOBAL SLEEP APNEA DIAGNOSTICS MARKET, FOR HOSPITALS & SLEEP LABORATORIES, BY REGION 20172025 ($MILLION)
  • TABLE 09. GLOBAL SLEEP APNEA DIAGNOSTICS MARKET, FOR HOME CARE SETTINGS, BY REGION, 20172025 ($MILLION)
  • TABLE 10. SLEEP APNEA DIAGNOSTICS MARKET, BY REGION, 20172025 ($MILLION)
  • TABLE 11. NORTH AMERICA SLEEP APNEA DIAGNOSTICS MARKET, BY COUNTRY, 20172025 ($MILLION)
  • TABLE 12. U.S. SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 13. U.S. SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 14. CANADA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 15. CANADA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 16. MEXICO. SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 17. MEXICO SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 18. NORTH AMERICA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 19. NORTH AMERICA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 20. EUROPE SLEEP APNEA DIAGNOSTICS MARKET, BY COUNTRY, 20172025 ($MILLION)
  • TABLE 21. GERMANY SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 22. GERMANY SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 23. UK SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 24. UK SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 25. FRANCE SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 26. FRANCE SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 27. ITALY SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 28. ITALY SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 29. SPAIN SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 30. SPAIN SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 31. REST OF EUROPE SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 32. REST OF EUROPE SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 33. EUROPE SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 34. EUROPE SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 35. ASIA-PACIFIC SLEEP APNEA DIAGNOSTICS MARKET, BY COUNTRY, 20172025 ($MILLION)
  • TABLE 36. JAPAN SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 37. JAPAN SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 38. CHINA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 39. CHINA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 40. INDIA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 41. INDIA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 42. AUSTRALIA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 43. AUSTRALIA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 44. REST OF ASIA-PACIFIC SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 45. REST OF ASIA-PACIFIC SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 46. ASIA-PACIFIC SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 47. ASIA-PACIFIC SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 48. LAMEA ALLERY END USER MARKET, BY COUNTRY, 20172025 ($MILLION)
  • TABLE 49. BRAZIL SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 50. BRAZIL SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 51. SOUTH AFRICA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 52. SOUTH AFRICA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 53. SAUDI ARABIA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 54. SAUDI ARABIA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 55. REST OF LAMEA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 56. REST OF LAMEA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 57. LAMEA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
  • TABLE 58. LAMEA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 59. CADWELL: COMPANY SNAPSHOT
  • TABLE 60. CADWELL: OPERATING SEGMENTS
  • TABLE 61. CADWELL: PRODUCT PORTFOLIO
  • TABLE 62. DEVILBISS: COMPANY SNAPSHOT
  • TABLE 63. DEVILBISS: PRODUCT PORTFOLIO
  • TABLE 64. PHILIPS: COMPANY SNAPSHOT
  • TABLE 65. PHILIPS: OPERATING SEGMENTS
  • TABLE 66. PHILIPS: PRODUCT PORTFOLIO
  • TABLE 67. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 68. MEDTRONIC: OPERATING SEGMENT
  • TABLE 69. MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 70. MINDRAY: COMPANY SNAPSHOT
  • TABLE 71. MINDRAY: OPERATING SEGMENTS
  • TABLE 72. NATUS: COMPANY SNAPSHOT
  • TABLE 73. NATUS: PRODUCT PORTFOLIO
  • TABLE 74. NIHON KOHDEN: COMPANY SNAPSHOT
  • TABLE 75. NIHON KOHDEN: OPERATING SEGMENTS
  • TABLE 76. NIHON: PRODUCT PORTFOLIO
  • TABLE 77. RESMED: COMPANY SNAPSHOT
  • TABLE 78. RESMED: PRODUCT PORTFOLIO
  • TABLE 79. SMITHS: COMPANY SNAPSHOT
  • TABLE 80. SMITHS: OPERATING SEGMENTS
  • TABLE 81. SMITHS: PRODUCT PORTFOLIO
  • TABLE 82. SOMNOMEDICS: COMPANY SNAPSHOT
  • TABLE 83. SOMNOMEDICS: PRODUCT PORTFOLIO

List of Figures

LIST OF FIGURES

  • FIGURE 01. SLEEP APNEA DIAGNOSTIC DEVICES MARKET SEGMENTATION
  • FIGURE 02. TOP INVESTMENT POCKETS
  • FIGURE 03. TOP PLAYER POSITIONING, 2017
  • FIGURE 04. GLOBAL SLEEP APNEA DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 05. COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKETFOR POLYSOMNOGRAPHY DEVICE (PSG) BY COUNTRY, 2017 & 2025 (%)
  • FIGURE 06. GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR CLINICAL PSG DEVICE, 20172025 ($MILLION)
  • FIGURE 07. GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR ABULATORS PSG DEVICE, 20172025 ($MILLION)
  • FIGURE 08. COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKET FOR SLEEP APNEA SCREENING DEVICE, BY COUNTRY, 2017 & 2025 (%)
  • FIGURE 09. COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKET FOR ACTIGRAPHY MONITORING DEVICE, BY COUNTRY, 2017 & 2025 (%)
  • FIGURE 10. COMPARATIVE SHARE ANALYSIS OF OTHER SLEEP APNEA DIAGNOSTICS MARKET FOR RESPIRATORY POLYGRAPH, BY COUNTRY, 2017 & 2025 (%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKET FOR OXIMETER, BY COUNTRY, 2017 & 2025 (%)
  • FIGURE 12. GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR FINGER TIP OXIMETER, 20172025 ($MILLION)
  • FIGURE 13. GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR HANDHELD OXIMETER, 20172025 ($MILLION)
  • FIGURE 14. MARKET SIZE AND FORECAST GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR WRIST WORN OXIMETER, 20172025 ($MILLION)
  • FIGURE 15. MARKET SIZE AND FORECAST GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR TABLE TOP OXIMETER, 20172025 ($MILLION)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKET, FOR RETAIL PHARMACIES, BY COUNTRY, 2017 & 2025 (%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKET FOR HOME CARE SETTINGS, BY COUNTRY 2017 & 2025 (%)
  • FIGURE 18. PHILIPS: NET SALES, 20152017 ($MILLION)
  • FIGURE 19. PHILIPS: REVENUE SHARE BY SEGMENT, 2017 (%)
  • FIGURE 20. PHILIPS: REVENUE SHARE BY REGION, 2017(%)
  • FIGURE 21. MEDTRONIC: NET SALES, 20152017 ($MILLION)
  • FIGURE 22. MEDTRONIC: REVENUE SHARE PER SEGMENT 2017(%)
  • FIGURE 23. MEDTRONIC: REVENUE SHARE BY REGION 2017(%)
  • FIGURE 24. NATUS: NET SALES, 20152017 ($MILLION)
  • FIGURE 25. NATUS: REVENUE SHARE BY PRODUCT, 2017 (%)
  • FIGURE 26. NATUS: REVENUE SHARE BY REGION, 2017 (%)
  • FIGURE 27. NIHON KOHDEN: NET SALES, 20152017 ($MILLION)
  • FIGURE 28. NIHON KOHDEN: REVENUE SHARE BY SEGMENT, 2017 (%)
  • FIGURE 29. NIHON KOHDEN: REVENUE SHARE BY REGION, 2017 (%)
  • FIGURE 30. RESMED: NET SALES, 20152017 ($MILLION)
  • FIGURE 31. RESMED: REVENUE SHARE BY REGION, 2017 (%)
  • FIGURE 32. SMITHS: NET SALES, 20152017 ($MILLION)
  • FIGURE 33. SMITHS: REVENUE SHARE BY DIVISION, 2017 (%)
  • FIGURE 34. SMITHS: REVENUE SHARE BY REGION, 2017 (%)
Back to Top